Summary
By using AdvSM patient samples at different stages of the disease (pre-treatment, remission, primary resistance, and relapse/ secondary resistance) project B09 will characterize the inflammatory cytokine landscape and immune cell composition and dynamically map the inflammatory microenvironment. Using established mouse models of AdvSM disease progression in the absence or presence of induced inflammation using different pro-inflammatory cytokines will be analyzed and compared to patient´s data. Multi-omic analysis will identify changes induced by differences in pro-inflammatory cytokine levels that impact on disease progression.
Lead Investigator
Prof. Dr. Andreas Reiter
Department of Hematology, Oncology and Rheumatology, Mannheim University Hospital

Lead Investigator
Dr. Marieke Essers
Division of Inflammatory Stress in Stem Cell, DKFZ, German Cancer Research Center, Heidelberg

Team:
Cell-Extrinsic Factors (Area B)











